CD96 and neoplasm: TIGIT, DNAM1, and CD96 (TACTILE) are known receptors for PVR in the immune system; binding of PVR to TIGIT suppresses tumor immunity while binding to DNAM1 promotes tumor immunity; binding to CD96 acts both to suppress and promote tumor immunity (10).